Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

NCT00452374 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Cytarabine
DRUG: Fludarabine
DRUG: Oxaliplatin
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]